ACTRN12617001370392
Completed
Not Applicable
2-Year Cerebral Performance Category at Hospital Discharge According To Initial Rhythm And Resuscitation Time
Konya Numune State Hospital0 sites44 target enrollmentSeptember 27, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- In-Hospital Cardiac Arrest
- Sponsor
- Konya Numune State Hospital
- Enrollment
- 44
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of indirect restorationsClass II caries lesionsCAD/CAM,Ceramic Block,Hybrid Block,Indirect RestorationTCTR20191212002Erciyes University60
Completed
Not Applicable
Clinical Assessment of Caries Restorations in the posterior tooth with bulk-fill resiDental CariesDental LeakageDental Restoration WearDental Restoration FailureC07.793.720.210C07.793.221E06.780.346.737.125E06.323.400RBR-9z6hx2Instituto de Ciência e Tecnologia - Universidade Estadual Paulista
Active, not recruiting
Not Applicable
A Phase II Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects with Acute Coronary Syndrome - CHI SQUARESymptoms of Acute Coronary SyndromeMedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.1Level: PTClassification code 10051592Term: Acute coronary syndromeEUCTR2010-023611-34-NLCerenis Therapeutics500
Active, not recruiting
Phase 1
A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects with Type 2 Diabetes Mellitus - P1736-05 POC studyDiabetes mellitus, type 2 (Blood Glucose Lowering Effect)EUCTR2009-016382-29-CZPiramal Life Sciences Limited20
Active, not recruiting
Not Applicable
A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects with Type 2 Diabetes Mellitus - P1736-05 POC studyDiabetes mellitus, type 2 (Blood Glucose Lowering Effect)/EUCTR2009-016382-29-HUPiramal Life Sciences Limited40